Insights

345 Park Avenue South

Xchange Challenge

All floors are lab-ready and cabled for digital health.

Community

Residents

Leadership

Staff

Neighborhood

Be part of *Cure.*

Orange

Where scientists, entrepreneurs and visionaries converge.

Campus

Ecosystem

Event Spaces

Gallery

Networking hub

Space Availability

A place to *Succeed.*

Green

Joe Wilson How Life Sciences Companies Use AI to Target Investors Mega Menu Image 

Critical Discussions Advancing Healthcare

Events

Event Inquiry

Past Events

Speakers

Tuesday Talks

Cure *Events.*

Magenta

Cure Clips

Tuesday Talks Series

Cure *Tuesday Talks*

Award Finalists to be announced soon!

Partnerships and Sponsorships

Women in Science

XSeed Award

Connect with *Opportunity.*

Blue

Network

Cure Insights Article A Bionic Pancreas that will Help Parents Sleep More Peacefully image for Cure Insights Mega Menu.  Image credit Cottonbro Studio.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

In-depth *Insights.*

About

Contact us

Stay updated on platform news and potential beta tests.

Regular

Kammy Moalemzadeh is the Founder & CEO of Arcadia Investment Partners, a New York based company for 21 years. Arcadia has backed numerous NY based companies and incubators, creating jobs in the state. 

Prior to founding Arcadia, Kammy was a Managing Director at Mentmore Holdings and a member of the merchant banking division of Donaldson, Lufkin and Jenrette. Moalemzadeh currently sits on the Board of Directors of SEO Sponsors for Educational Opportunity, a non profit organization providing supplemental educational and career support to young people from underserved communities.

Moalemzadeh graduated from the Wharton School of the University of Pennsylvania.

CEO, Arcadia Investment Partners

The Cure X experience is dedicated to providing a comprehensive overview of the current state of rare diseases in the United States. With over 30 million Americans affected by these afflictions, the event features distinguished speakers and world-renowned experts from various fields, including patients, advocates, entrepreneurs, physicians, and scientists. Participants will gain invaluable insights into the latest innovations, discoveries, frustrations, hopes, and fears related to the nearly 7,000 rare diseases that could potentially impact them or their loved ones.

We Are All Unique: A Frank Discussion about Rare Diseases